Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

When to treat ocular hypertension.

M A Kass

    Survey of Ophthalmology
    |December 1, 1983
    PubMed
    Summary

    Ocular hypertension affects 4-10% of adults over 40. Prophylactic treatment is recommended for high-risk individuals to prevent primary open-angle glaucoma.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial (1).

    Journal of glaucoma·2009
    Same author

    Ocular hypertension treatment study: design issues.

    Journal of glaucoma·2009
    Same author

    Chronic uveitis and glaucoma.

    Journal of glaucoma·2009
    Same author

    The ocular hypertension treatment study.

    Journal of glaucoma·2009
    Same author

    Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS).

    Ophthalmology·2001
    Same author

    Clinical factors associated with progression of glaucomatous optic disc damage in treated patients.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2001

    Area of Science:

    • Ophthalmology
    • Glaucoma Research

    Background:

    • Ocular hypertension, defined as intraocular pressure ≥ 21 mm Hg with normal ocular structures and function, affects 4-10% of individuals over 40.
    • The decision to treat ocular hypertension remains a subject of clinical debate.
    • Primary open-angle glaucoma is a potential consequence of untreated ocular hypertension.

    Purpose of the Study:

    • To evaluate the criteria for recommending prophylactic treatment in ocular hypertensive patients.
    • To identify high-risk factors associated with the progression of ocular hypertension to primary open-angle glaucoma.

    Main Methods:

    • Review of risk factors for glaucoma development in patients with ocular hypertension.
    • Analysis of clinical indicators and patient-specific factors influencing treatment decisions.

    Main Results:

    • Key risk factors for progression include elevated intraocular pressure, optic disc abnormalities, advanced age, family history of glaucoma, and systemic vascular disease.
    • Specific patient characteristics, such as young age, monocularity, unreliability for testing, inability to perform reliable visual fields, patient preference, or history of retinal vascular occlusion, favor prophylactic treatment.

    Conclusions:

    • Prophylactic treatment is recommended for selected ocular hypertensive patients at high risk of developing primary open-angle glaucoma.
    • Treatment decisions should consider a combination of ocular parameters, systemic health, and individual patient factors.

    Related Experiment Videos